The double-digit growth is in line with the trend of private medical market, an extremely effervescent area in recent years.
The group estimates a net profit of RON21.8 million for this year, according to its spending and revenue budget, after having posted RON4.1 million loss in 2023. In addition, MedLife wants to increase its EBITDA by 29% to RON372 million.
In terms of challenges, the MedLife group expects inflation, rising tariffs, raw material prices or fiscal or monetary changes to influence the business again in 2024.
(English version by Loredana Fratila-Cristescu)